Gateway Bio, Inc.
Last verified 2026-05-21. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $1.3Mattributed |
|---|---|
| Latest round | grant, $1.3M, 2024-01-01attributed |
| Founded | unknown |
| Headquarters | durham, nc, usa |
| Industry | unknown |
| Stage | unknown |
| Website | gateway bio, inc. |
Gateway Bio is a biotechnology company focused on translational drug development across early-stage pipeline assets. Public information is limited; the company is positioned in the broader therapeutics space. The web presence does not currently advertise specific platforms.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-01-01 | grant | $1.3M | undisclosed |
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $1.3M | attributed | sbir named as publisher. No document URL on file. |
| Total raised $1.3M | attributed | sbir named as publisher. No document URL on file. |
| Company existence | self-reported | gateway bio, inc., read 2026-05-21 |
| Description | self-reported | gateway bio, inc., read 2026-05-21 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.